{"entity":{"type":"insider","cik":"0001363213","url":"/insider/0001363213","json_url":"/insider/0001363213.json","name":"Blobel Friedhelm","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":104,"n_filings":60,"first":"2007-11-20","last":"2017-07-03","span_basis":"filed_date"},"name_variants":[{"name":"Blobel Friedhelm","source":"filing","n_filings":60,"first_seen":"2007-11-20","last_seen":"2017-07-03"}],"transactions":[{"id":4603748,"accession":"0000880771-17-000120","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-17-000120","line_url":"/filing/0000880771-17-000120","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35044.0,"shares_display":"35,044","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":385484.0,"total_display":"385,484.00","total_whole":"385,484","shares_owned_after":122209.0,"shares_owned_after_display":"122,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-30","filed_date":"2017-07-03","scope":"insider","n_lines":2},{"id":5337959,"accession":"0000880771-17-000118","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-17-000118","line_url":"/filing/0000880771-17-000118","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":10.908957142857142,"price_display":"10.91","price_state":"stated","total_value":763627.0,"total_display":"763,627.00","total_whole":"763,627","shares_owned_after":122209.0,"shares_owned_after_display":"122,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-20","filed_date":"2017-06-22","scope":"insider","n_lines":2},{"id":4389655,"accession":"0000880771-17-000104","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-17-000104","line_url":"/filing/0000880771-17-000104#line-4","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19956.0,"shares_display":"19,956","price_per_share":11.0046,"price_display":"11.00","price_state":"stated","total_value":219607.7976,"total_display":"219,607.80","total_whole":"219,608","shares_owned_after":93299.0,"shares_owned_after_display":"93,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-08","filed_date":"2017-06-09","scope":"insider"},{"id":4389649,"accession":"0000880771-17-000104","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000104","line_url":"/filing/0000880771-17-000104#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19700.0,"shares_display":"19,700","price_per_share":10.0266,"price_display":"10.03","price_state":"stated","total_value":197524.02,"total_display":"197,524.02","total_whole":"197,524","shares_owned_after":93299.0,"shares_owned_after_display":"93,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-07","filed_date":"2017-06-09","scope":"insider"},{"id":4767141,"accession":"0000880771-17-000091","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-17-000091","line_url":"/filing/0000880771-17-000091#line-4","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":55000.0,"total_display":"55,000.00","total_whole":"55,000","shares_owned_after":93299.0,"shares_owned_after_display":"93,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-06","filed_date":"2017-06-06","scope":"insider"},{"id":4767131,"accession":"0000880771-17-000091","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000091","line_url":"/filing/0000880771-17-000091#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":48000.0,"total_display":"48,000.00","total_whole":"48,000","shares_owned_after":93299.0,"shares_owned_after_display":"93,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-02","filed_date":"2017-06-06","scope":"insider"},{"id":4727815,"accession":"0000880771-17-000088","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-17-000088","line_url":"/filing/0000880771-17-000088#line-4","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6298.0,"shares_display":"6,298","price_per_share":9.3641,"price_display":"9.36","price_state":"stated","total_value":58975.1018,"total_display":"58,975.10","total_whole":"58,975","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-24","filed_date":"2017-05-25","scope":"insider"},{"id":4727800,"accession":"0000880771-17-000088","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000088","line_url":"/filing/0000880771-17-000088#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15166.0,"shares_display":"15,166","price_per_share":9.3073,"price_display":"9.31","price_state":"stated","total_value":141154.5118,"total_display":"141,154.51","total_whole":"141,155","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-23","filed_date":"2017-05-25","scope":"insider"},{"id":5305073,"accession":"0000880771-17-000085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000085","line_url":"/filing/0000880771-17-000085#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18536.0,"shares_display":"18,536","price_per_share":9.4425,"price_display":"9.44","price_state":"stated","total_value":175026.18,"total_display":"175,026.18","total_whole":"175,026","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-22","filed_date":"2017-05-23","scope":"insider"},{"id":4249739,"accession":"0000880771-17-000082","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000082","line_url":"/filing/0000880771-17-000082#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18226.0,"shares_display":"18,226","price_per_share":10.003,"price_display":"10.00","price_state":"stated","total_value":182314.678,"total_display":"182,314.68","total_whole":"182,315","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-11","filed_date":"2017-05-15","scope":"insider"},{"id":4179616,"accession":"0000880771-17-000073","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000073","line_url":"/filing/0000880771-17-000073#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":164.0,"shares_display":"164","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":1640.0,"total_display":"1,640.00","total_whole":"1,640","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-03","scope":"insider"},{"id":4689627,"accession":"0000880771-17-000069","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000880771-17-000069","line_url":"/filing/0000880771-17-000069#line-6","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","total_whole":"2,000","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-28","filed_date":"2017-04-28","scope":"insider"},{"id":4689615,"accession":"0000880771-17-000069","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-17-000069","line_url":"/filing/0000880771-17-000069#line-4","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":10.0081,"price_display":"10.01","price_state":"stated","total_value":28022.68,"total_display":"28,022.68","total_whole":"28,023","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-27","filed_date":"2017-04-28","scope":"insider"},{"id":4689606,"accession":"0000880771-17-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000069","line_url":"/filing/0000880771-17-000069#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":14000.0,"total_display":"14,000.00","total_whole":"14,000","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-26","filed_date":"2017-04-28","scope":"insider"},{"id":4522005,"accession":"0000880771-17-000067","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000880771-17-000067","line_url":"/filing/0000880771-17-000067#line-6","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12160.0,"shares_display":"12,160","price_per_share":9.6405,"price_display":"9.64","price_state":"stated","total_value":117228.48,"total_display":"117,228.48","total_whole":"117,228","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-24","filed_date":"2017-04-24","scope":"insider"},{"id":4521998,"accession":"0000880771-17-000067","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-17-000067","line_url":"/filing/0000880771-17-000067#line-4","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16162.0,"shares_display":"16,162","price_per_share":9.4747,"price_display":"9.47","price_state":"stated","total_value":153130.1014,"total_display":"153,130.10","total_whole":"153,130","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-21","filed_date":"2017-04-24","scope":"insider"},{"id":4521988,"accession":"0000880771-17-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000067","line_url":"/filing/0000880771-17-000067#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11678.0,"shares_display":"11,678","price_per_share":9.6002,"price_display":"9.60","price_state":"stated","total_value":112111.1356,"total_display":"112,111.14","total_whole":"112,111","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-20","filed_date":"2017-04-24","scope":"insider"},{"id":5049933,"accession":"0000880771-17-000061","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-17-000061","line_url":"/filing/0000880771-17-000061#line-4","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9662.0,"shares_display":"9,662","price_per_share":9.3279,"price_display":"9.33","price_state":"stated","total_value":90126.1698,"total_display":"90,126.17","total_whole":"90,126","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-22","filed_date":"2017-03-23","scope":"insider"},{"id":5049924,"accession":"0000880771-17-000061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000061","line_url":"/filing/0000880771-17-000061#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30338.0,"shares_display":"30,338","price_per_share":9.5094,"price_display":"9.51","price_state":"stated","total_value":288496.1772,"total_display":"288,496.18","total_whole":"288,496","shares_owned_after":92526.0,"shares_owned_after_display":"92,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-21","filed_date":"2017-03-23","scope":"insider"},{"id":4885305,"accession":"0000880771-17-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000032","line_url":"/filing/0000880771-17-000032#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3087.0,"shares_display":"3,087","price_per_share":10.297,"price_display":"10.30","price_state":"stated","total_value":31786.839,"total_display":"31,786.84","total_whole":"31,787","shares_owned_after":87526.0,"shares_owned_after_display":"87,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-06","filed_date":"2017-03-08","scope":"insider"},{"id":4331343,"accession":"0000880771-17-000028","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000880771-17-000028","line_url":"/filing/0000880771-17-000028","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13296.0,"shares_display":"13,296","price_per_share":10.0267,"price_display":"10.03","price_state":"stated","total_value":133315.0032,"total_display":"133,315.00","total_whole":"133,315","shares_owned_after":87526.0,"shares_owned_after_display":"87,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-03","filed_date":"2017-03-03","scope":"insider","n_lines":2},{"id":4331324,"accession":"0000880771-17-000028","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-17-000028","line_url":"/filing/0000880771-17-000028#line-4","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4417.0,"shares_display":"4,417","price_per_share":10.0063,"price_display":"10.01","price_state":"stated","total_value":44197.8271,"total_display":"44,197.83","total_whole":"44,198","shares_owned_after":87526.0,"shares_owned_after_display":"87,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-02","filed_date":"2017-03-03","scope":"insider"},{"id":4331316,"accession":"0000880771-17-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000028","line_url":"/filing/0000880771-17-000028#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9200.0,"shares_display":"9,200","price_per_share":10.0011,"price_display":"10.00","price_state":"stated","total_value":92010.12,"total_display":"92,010.12","total_whole":"92,010","shares_owned_after":87526.0,"shares_owned_after_display":"87,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-03","scope":"insider"},{"id":4249733,"accession":"0000880771-17-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000020","line_url":"/filing/0000880771-17-000020#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":823.0,"shares_display":"823","price_per_share":9.7125,"price_display":"9.71","price_state":"stated","total_value":7993.3875,"total_display":"7,993.39","total_whole":"7,993","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-24","filed_date":"2017-02-27","scope":"insider"},{"id":5049911,"accession":"0000880771-17-000016","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000880771-17-000016","line_url":"/filing/0000880771-17-000016#line-6","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9800.0,"shares_display":"9,800","price_per_share":9.756,"price_display":"9.76","price_state":"stated","total_value":95608.8,"total_display":"95,608.80","total_whole":"95,609","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-23","filed_date":"2017-02-23","scope":"insider"},{"id":5049905,"accession":"0000880771-17-000016","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-17-000016","line_url":"/filing/0000880771-17-000016#line-4","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9201.0,"shares_display":"9,201","price_per_share":9.8591,"price_display":"9.86","price_state":"stated","total_value":90713.5791,"total_display":"90,713.58","total_whole":"90,714","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-22","filed_date":"2017-02-23","scope":"insider"},{"id":5049898,"accession":"0000880771-17-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000016","line_url":"/filing/0000880771-17-000016#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20176.0,"shares_display":"20,176","price_per_share":9.861,"price_display":"9.86","price_state":"stated","total_value":198955.536,"total_display":"198,955.54","total_whole":"198,956","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-21","filed_date":"2017-02-23","scope":"insider"},{"id":4885298,"accession":"0000880771-17-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000010","line_url":"/filing/0000880771-17-000010#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8868.0,"shares_display":"8,868","price_per_share":10.5367,"price_display":"10.54","price_state":"stated","total_value":93439.4556,"total_display":"93,439.46","total_whole":"93,439","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-25","filed_date":"2017-01-27","scope":"insider"},{"id":4807187,"accession":"0000880771-17-000008","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000880771-17-000008","line_url":"/filing/0000880771-17-000008","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25925.0,"shares_display":"25,925","price_per_share":10.491260783027965,"price_display":"10.49","price_state":"stated","total_value":271985.9358,"total_display":"271,985.94","total_whole":"271,986","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-24","filed_date":"2017-01-24","scope":"insider","n_lines":2},{"id":4807154,"accession":"0000880771-17-000008","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000880771-17-000008","line_url":"/filing/0000880771-17-000008","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22807.0,"shares_display":"22,807","price_per_share":10.4138,"price_display":"10.41","price_state":"stated","total_value":237507.5366,"total_display":"237,507.54","total_whole":"237,508","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-23","filed_date":"2017-01-24","scope":"insider","n_lines":2},{"id":4807118,"accession":"0000880771-17-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000008","line_url":"/filing/0000880771-17-000008#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12400.0,"shares_display":"12,400","price_per_share":10.3823,"price_display":"10.38","price_state":"stated","total_value":128740.52,"total_display":"128,740.52","total_whole":"128,741","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-20","filed_date":"2017-01-24","scope":"insider"},{"id":4645060,"accession":"0000880771-17-000003","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000880771-17-000003","line_url":"/filing/0000880771-17-000003#line-6","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9200.0,"shares_display":"9,200","price_per_share":11.0204,"price_display":"11.02","price_state":"stated","total_value":101387.68,"total_display":"101,387.68","total_whole":"101,388","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-05","filed_date":"2017-01-05","scope":"insider"},{"id":4645048,"accession":"0000880771-17-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-17-000003","line_url":"/filing/0000880771-17-000003#line-4","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":1100.0,"total_display":"1,100.00","total_whole":"1,100","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-04","filed_date":"2017-01-05","scope":"insider"},{"id":4645035,"accession":"0000880771-17-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000003","line_url":"/filing/0000880771-17-000003#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":3300.0,"total_display":"3,300.00","total_whole":"3,300","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-05","scope":"insider"},{"id":2229527,"accession":"0000880771-16-000217","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000880771-16-000217","line_url":"/filing/0000880771-16-000217#line-6","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6901.0,"shares_display":"6,901","price_per_share":10.3967,"price_display":"10.40","price_state":"stated","total_value":71747.6267,"total_display":"71,747.63","total_whole":"71,748","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-22","filed_date":"2016-12-22","scope":"insider"},{"id":2229520,"accession":"0000880771-16-000217","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-16-000217","line_url":"/filing/0000880771-16-000217","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63099.0,"shares_display":"63,099","price_per_share":10.564654755225915,"price_display":"10.56","price_state":"stated","total_value":666619.1504,"total_display":"666,619.15","total_whole":"666,619","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-21","filed_date":"2016-12-22","scope":"insider","n_lines":2},{"id":2813450,"accession":"0000880771-16-000215","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000880771-16-000215","line_url":"/filing/0000880771-16-000215#line-6","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14147.0,"shares_display":"14,147","price_per_share":10.1976,"price_display":"10.20","price_state":"stated","total_value":144265.4472,"total_display":"144,265.45","total_whole":"144,265","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-22","filed_date":"2016-11-23","scope":"insider"},{"id":2813446,"accession":"0000880771-16-000215","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-16-000215","line_url":"/filing/0000880771-16-000215","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55853.0,"shares_display":"55,853","price_per_share":10.221711276028145,"price_display":"10.22","price_state":"stated","total_value":570913.2399,"total_display":"570,913.24","total_whole":"570,913","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-21","filed_date":"2016-11-23","scope":"insider","n_lines":2},{"id":2813433,"accession":"0000880771-16-000210","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-16-000210","line_url":"/filing/0000880771-16-000210#line-4","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24699.0,"shares_display":"24,699","price_per_share":10.3278,"price_display":"10.33","price_state":"stated","total_value":255086.3322,"total_display":"255,086.33","total_whole":"255,086","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-14","filed_date":"2016-11-15","scope":"insider"},{"id":2813426,"accession":"0000880771-16-000210","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-16-000210","line_url":"/filing/0000880771-16-000210#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5301.0,"shares_display":"5,301","price_per_share":10.0078,"price_display":"10.01","price_state":"stated","total_value":53051.3478,"total_display":"53,051.35","total_whole":"53,051","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-11","filed_date":"2016-11-15","scope":"insider"},{"id":3194070,"accession":"0000880771-16-000202","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-16-000202","line_url":"/filing/0000880771-16-000202#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":9.2973,"price_display":"9.30","price_state":"stated","total_value":371892.0,"total_display":"371,892.00","total_whole":"371,892","shares_owned_after":86784.0,"shares_owned_after_display":"86,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-27","filed_date":"2016-10-28","scope":"insider"},{"id":3068781,"accession":"0000880771-16-000187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-16-000187","line_url":"/filing/0000880771-16-000187#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":501875.0,"shares_display":"501,875","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5018750.0,"total_display":"5,018,750.00","total_whole":"5,018,750","shares_owned_after":86380.0,"shares_owned_after_display":"86,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-17","filed_date":"2016-08-18","scope":"insider"},{"id":2186505,"accession":"0001363213-16-000071","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001363213-16-000071","line_url":"/filing/0001363213-16-000071#line-4","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001363213","owner_name":"Blobel Friedhelm","owner_display_name":"Blobel Friedhelm","owner_url":"/insider/0001363213","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9160.0,"shares_display":"9,160","price_per_share":9.2878,"price_display":"9.29","price_state":"stated","total_value":85076.248,"total_display":"85,076.25","total_whole":"85,076","shares_owned_after":205252.0,"shares_owned_after_display":"205,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-28","filed_date":"2016-03-30","scope":"insider"}],"collapsed":true,"next_cursor":"2016-03-28|2186505","ledger_fault":false,"count":{"value":104,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":26,"open_market":true},{"code":"S","label":"Open-market sale","n":78,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":104},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000880771","name":"SCICLONE PHARMACEUTICALS INC","url":"/issuer/0000880771","role":"Director, Officer (President & CEO)","n_filings":60,"first_seen":"2007-11-20","last_seen":"2017-07-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001363213","retrieved_at":"2026-08-25T18:21:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}